论文部分内容阅读
将174例确诊为MS的高血压患者随机分为两组,治疗组98例,对照组76例,治疗组予以蒙诺和施慧达治疗,对照组予以施慧达治疗,治疗3个月。结果:治疗组和对照组各观察指标均有降低,治疗组的收缩压和舒张压降低明显,组间降压效果明显差异减少尿微量白蛋白的排泄;对照组的副作用比较明显。结论:蒙诺联用施慧达治疗伴MS的高血压是目前较好的治疗方案。
A total of 174 hypertensive patients diagnosed as MS were randomly divided into two groups: 98 cases in the treatment group and 76 cases in the control group. The patients in the treatment group were treated with Monroe and Shi Huida, and the control group was treated with Shihui Da for 3 months. Results: The treatment group and the control group were reduced in all indicators, the treatment group systolic blood pressure and diastolic blood pressure significantly reduced the effect of antihypertensive effect was significantly reduced urine microalbumin excretion; the side effects of the control group more obvious. Conclusion: Monel combined with Shi Huida treatment of MS with hypertension is the better treatment.